Mayo Clinic study identifies five distinct biological subtypes of fatty liver disease
Researchers at the Mayo Clinic have shown that metabolic dysfunction-associated steatotic liver disease is not a single condition but a cluster of five molecularly distinct entities, each with differing complication profiles.
Researchers at the Mayo Clinic have published findings indicating that fatty liver disease — now more precisely termed metabolic dysfunction-associated steatotic liver disease (MASLD) — comprises five biologically distinct subtypes rather than a single condition. The study, reported by ScienceDaily, involved characterisation of a large patient cohort, with each subtype distinguished by differing molecular and clinical signatures.
The five subtypes were found to carry substantially different risks for downstream complications, including liver failure, hepatocellular carcinoma, cardiovascular disease, and metabolic disorders. The authors argue that this heterogeneity may partly explain why clinical trials targeting MASLD as a single entity have produced variable results, and why some patients progress rapidly while others remain stable over many years.
The research employed multi-omic profiling — combining genomic, proteomic, and clinical data — to construct the subtype classifications. The team reports that the subtypes were reproducible across independent validation cohorts, though the study's scope and journal of publication were not fully detailed in the available feed summary.
If the subtype framework is validated in further independent work, it could influence how researchers design future studies of liver disease mechanisms and how experimental therapies are evaluated. The Mayo Clinic team notes that their findings are intended to refine the scientific understanding of MASLD's complexity. Full details of the journal and authorship were not available from the source feed at time of writing.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
A very common liver condition, sometimes called fatty liver disease, has long been treated by doctors as if it were one disease. New research from the Mayo Clinic in the United States suggests it is actually five different conditions that happen to look similar on the surface, but differ in their underlying biology and in the health complications they can cause.
Scientists used detailed analysis of patients' genes and proteins to identify these five types. They hope that understanding these differences will help researchers design better studies and, in future, more targeted treatments.
This research does not change current guidance on fatty liver disease management. It is an early step towards a better scientific understanding.
This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source ScienceDaily · 2026-10-19Fatty liver disease is actually five different conditions, scientists discover